Navigation Links
Latest coffee and health research to be debated at the World Congress on Prevention of Diabetes

Recent scientific evidence has consistently linked regular, moderate coffee consumption with a reduced risk of developing type 2 diabetes. An update of this research will be presented by experts working in this field at the World Congress on Prevention of Diabetes and Its Complications (WCPD), taking place on 11-14 November in Madrid, Spain.

The parallel session "Good things in life: Can coffee help in diabetes prevention?" will take place on Monday, 12 November at 11:30 a.m. It is sponsored by the Institute for Scientific Information on Coffee, a not-for-profit organisation devoted to the study and disclosure of science related to coffee and health.

The panel will be chaired by Dr. Pablo Aschner, Associate Professor of Endocrinology at the Javeriana University School of Medicine and Siamak Bidel, Senior Researcher at the University of Helsinki. Four speakers will present an update of recent research on different aspects of coffee and diabetes, followed by a panel discussion and an open debate.

Professor Jaakko Tuomilehto, Professor of Public Health at the University of Helsinki, will present the latest results from coffee intervention trials, building on existing work showing that drinking 3 to 4 cups of coffee per day is associated with an approximate 25% lower risk of developing type 2 diabetes, compared to consuming none or less than 2 cups per day.

Dr. Pilar Riob Servn, Associate Chief of Endocrinology and Nutrition at the Jimnez Daz-Capio Hospital of Madrid, will discuss the significance of clinical parameters found so far regarding coffee and diabetes.

Dr. Nathan Matusheski, Senior Scientist at Kraft Foods, will be looking at the potential mechanisms that may govern the relationship between coffee and type 2 diabetes, highlighting the potential role of antioxidants in coffee, such as chlorogenic acid and trigonelline.

Professor Edith Feskens, Professor of Nutrition and Epidemiology at the National Institute of Public Health and the Environment in the Netherlands, will end the presentations with an overview of the epidemiological evidence relating to coffee and reduced risk of type 2 diabetes.

Based on the increasing scientific evidence that links regular, moderate coffee consumption with a reduced risk of developing type 2 diabetes, ISIC believed it was relevant to sponsor this session in order to increase awareness amongst experts on diabetes and prevention and help them to educate the public and eradicate misconceptions about coffee and health not based on solid scientific evidence.

Contact: Emma Knott
European Science Foundation

Related medicine news :

1. Register now! San Diego meeting will showcase latest aging discoveries
2. Dengue Vaccine Initiative welcomes latest progress in vaccine development
3. The latest science and treatments in emergency cardiac care
4. Meeting in Jordan to educate medical professionals on latest advances in osteoporosis
5. UT Southwestern investigators awarded $48.2 million in latest round of CPRIT grants
6. Elinext Leverages Latest QR Code and NFC Technologies in Mobile App Development for Retailers, Manufacturers, Advertisers, and Real Estate Companies
7. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
8. Heavy Coffee Intake May Affect Fertility Treatments: Study
9. 5 or more cups of coffee a day reduce the chance of IVF success by around 50 percent
10. Coffee May Cut Your Risk for Common Form of Skin Cancer
11. Coffee consumption inversely associated with risk of most common form of skin cancer
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, ... country to celebrate their sobriety and show through pictures what a positive difference ... photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 23rd 2015 Cozy Products, ... heating products business. Cozy Products explains what this means for business moving forward. , ... the Cozy Products business model: to sell personal heaters that reduce energy consumption, are ...
(Date:11/25/2015)... Livonia, MI (PRWEB) , ... November 25, 2015 , ... ... at Presence Resurrection Medical Center (RMC) in Chicago, IL, UV Angel is evaluating the ... the medical and surgical intensive care units (totaling 30 beds) from May 2014 through ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... found that regular bras were incredibly uncomfortable," said an inventor from Bronx, N.Y. ... , She developed the patent-pending RECOVERY BRA for added comfort and support. The ...
(Date:11/25/2015)... ... , ... Since its launch in 2012, the Regenestem brand ... therapies to patients with chronic degenerative medical conditions. Now, the U.S. Patent and ... , Organizations are required to hold a registered trademark in order to make ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Thanks to a donor with a ... Medical Center,s Sister Diane Grassilli Center for Women,s Health ... San Francisco . ... forward with a gift of $617,320 that allowed the ... with Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) ...
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
Breaking Medicine Technology: